Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence. Read more about Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence.
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets. Read more about Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.
Specific binding of GPR174 by endogenous lysophosphatidylserine leads to high constitutive Gs signaling. Read more about Specific binding of GPR174 by endogenous lysophosphatidylserine leads to high constitutive Gs signaling.
VE-cadherin in arachnoid and pia mater cells serves as a suitable landmark for in vivo imaging of CNS immune surveillance and inflammation. Read more about VE-cadherin in arachnoid and pia mater cells serves as a suitable landmark for in vivo imaging of CNS immune surveillance and inflammation.
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia. Read more about MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.
Next-generation proteomics for quantitative Jumbophage-bacteria interaction mapping. Read more about Next-generation proteomics for quantitative Jumbophage-bacteria interaction mapping.
Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis. Read more about Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis.
Stepwise modifications of transcriptional hubs link pioneer factor activity to a burst of transcription. Read more about Stepwise modifications of transcriptional hubs link pioneer factor activity to a burst of transcription.
Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection. Read more about Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection.
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma. Read more about UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.
